The following drugs were used: acetylcholine, 4-aminopyridine, apamin, 4′-hydroxy-3′-methoxyacetophenone (apocynin), barium chloride, cocaine, glibenclamide, guanethidine, 5-HT, iberiotoxin, indomethacin, L-NOARG, N
omega-propyl-L-arginine, phentolamine, ouabain, prazosin, propranolol, SOD,
tetrodotoxin, TEA and
1-(2-Chlorophenyl) diphenylmethyl- 1H-pyrazole (TRAM-34) (Sigma Chemical Co, St Louis, MO, USA).
NS-398,
SC-560 and 1400 W were purchased from Tocris Cookson (Bristol, UK). Bosentan was a gift from F. Hoffman-La Roche Laboratories (Basel, Switzerland).
All drugs were added in volumes not exceeding 0.3% of the organ baths to reach the final required concentration. They were dissolved in distilled water with the exception of indomethacin which was prepared in ethanol (96%), glibenclamide,
SC-560 and
NS-398 which required dimethylsulphoxide (10%). Preliminary experiments revealed no effects of the solvent used on the contractility of the preparations. Stock solutions were prepared and stored at −20°C and fresh solutions were prepared daily.
Martínez A.C., Hernández M., Novella S., Martínez M.P., Pagán R.M., Hermenegildo C., García-Sacristán A., Prieto D, & Benedito S. (2014). Diminished Neurogenic Femoral Artery Vasoconstrictor Response in a Zucker Obese Rat Model: Differential Regulation of NOS and COX Derivatives. PLoS ONE, 9(9), e106372.